SIGHT SCIENCES INC's ticker is and the CUSIP is 82657M105. A total of 67 filers reported holding SIGHT SCIENCES INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.9%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $222 | +74.8% | 66,000 | +331.4% | 0.00% | – |
Q2 2023 | $127 | -99.9% | 15,300 | -51.6% | 0.00% | – |
Q3 2022 | $201,000 | -20.9% | 31,586 | +11.6% | 0.00% | – |
Q2 2022 | $254,000 | -24.2% | 28,300 | -2.4% | 0.00% | – |
Q1 2022 | $335,000 | -61.4% | 29,000 | -41.3% | 0.00% | -100.0% |
Q4 2021 | $868,000 | – | 49,400 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
KCK LTD. | 4,776,232 | $42,938,000 | 60.33% |
Sio Capital Management, LLC | 724,944 | $6,517,000 | 2.45% |
D1 Capital Partners L.P. | 5,852,036 | $52,610,000 | 1.25% |
PFM Health Sciences, LP | 776,281 | $6,979,000 | 0.27% |
RTW INVESTMENTS, LP | 997,099 | $8,964,000 | 0.23% |
ArrowMark Colorado Holdings LLC | 1,587,305 | $14,270,000 | 0.16% |
Jackson Square Partners, LLC | 595,051 | $5,349,000 | 0.12% |
Atom Investors LP | 11,181 | $101,000 | 0.04% |
Bellevue Group AG | 294,606 | $2,649,000 | 0.04% |
Orbimed Advisors | 200,000 | $1,798,000 | 0.03% |